StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.13+0.01 (+7.08%)

Close on Nov 19, 2026Market cap $6.64MP/E –Yield –

AEON Biopharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for AEON Biopharma

AEON Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More AEON Biopharma figures

See a number that looks wrong?